Genetic testing company Myriad Genetics (NASDAQ:MYGN) will be reporting earnings this Tuesday after market close. Here’s what ...

Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing ...

The Food and Drug Administration accepted Opus Genetics's investigational gene therapy into its Rare Disease Evidence Principles program, the company said Monday. The clinical-stage biopharmaceutical ...

Corteva has renamed its new seed and genetics company as the company moves to split into two separate businesses.

The company announced the spinoff plan last year and the separation is planned for the fourth quarter of 2026. Vylor will have more than 4,000 germplasm patents and 2,000 biotechnology patents and a ...

After centuries of mystery, scientists are edging closer to uncovering Leonardo da Vinci’s biological secrets. A massive ...

New research looking at whether low-emitting bulls pass these traits onto their milking daughters has suffered a ...

National Eye Institute (NEI) scientists have found that the way the retina metabolizes glucose directly controls which genes get switched on and off in light-sensing photoreceptors. The findings ...

Healthcare AI stocks are getting more attention as investors look for places where artificial intelligence can move beyond ...

Hebbevu Genetics, a cattle genetics company driving productivity through science-led breeding systems, has initiated a global ...

After a cancer diagnosis, patients often have many questions, not only about their treatment but also about what the ...

U.S. agriscience company Corteva on Monday said it is naming the advanced seed and genetics unit it plans to spin off Vylor, ...